What is it about?
Primary ciliary dyskinesia is a rare, genetically heterogeneous lung disease. We describe how human induced pluripotent stem cells could be used to model this disease for the development of innovative patient-specific biotherapies
Featured Image
Read the Original
This page is a summary of: Induced Pluripotent Stem Cells for Primary Ciliary Dyskinesia Modeling and Personalized Medicine, American Journal of Respiratory Cell and Molecular Biology, December 2018, American Thoracic Society,
DOI: 10.1165/rcmb.2018-0213tr.
You can read the full text:
Contributors
The following have contributed to this page
